본문 바로가기
KERD
논문KCI 등재

Impact of Intravenous Omega-3-Enriched Lipid Emulsion on Liver Enzyme and Triglyceride Serum Levels of Children Undergoing Gastrointestinal Surgery

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: To investigate the impact of omega-3-enriched lipid emulsion (LE) on liver enzyme (aspartate transaminase [AST] and alanine aminotransferase [ALT]) and triglyceride (TG) levels of children undergoing gastrointestinal surgery. Methods: This experimental randomized controlled group pretest-posttest design study included 14 children who underwent gastrointestinal surgery due to duodenal atresia, jejunal atresia, esophageal atresia, and need for parenteral nutrition for a minimum of 3 days at RSUD Dr. Soetomo Surabaya between August 2018 and January 2019. These children were divided into two groups, those who received standard intravenous LE (medium-chain triglyceride [MCT]/long-chain triglyceride [LCT]) and those who received intravenous omega-3-enriched LE. Differences in AST, ALT, and TG levels were measured before surgery and 3 days after the administration of parenteral nutrition. Results: Liver enzyme and TG levels in each group did not differ significantly before versus 3 days after surgery. However, TG levels were significantly lower in the omega-3-enriched intravenous LE group (p=0.041) at 3 days after surgery, and statistically significant difference in changes in TG levels was noted at 3 days after surgery between MCT/LCT intravenous LE group and the omega-3-enriched intravenous LE group (p=0.008). Conclusion: The intravenous omega-3-enriched LE had a better TG-lowering effect than the MCT/LCT intravenous LE in children undergoing gastrointestinal surgery.

Abstract

Purpose: To investigate the impact of omega-3-enriched lipid emulsion (LE) on liver enzyme (aspartate transaminase [AST] and alanine aminotransferase [ALT]) and triglyceride (TG) levels of children undergoing gastrointestinal surgery. Methods: This experimental randomized controlled group pretest-posttest design study included 14 children who underwent gastrointestinal surgery due to duodenal atresia, jejunal atresia, esophageal atresia, and need for parenteral nutrition for a minimum of 3 days at RSUD Dr. Soetomo Surabaya between August 2018 and January 2019. These children were divided into two groups, those who received standard intravenous LE (medium-chain triglyceride [MCT]/long-chain triglyceride [LCT]) and those who received intravenous omega-3-enriched LE. Differences in AST, ALT, and TG levels were measured before surgery and 3 days after the administration of parenteral nutrition. Results: Liver enzyme and TG levels in each group did not differ significantly before versus 3 days after surgery. However, TG levels were significantly lower in the omega-3-enriched intravenous LE group (p=0.041) at 3 days after surgery, and statistically significant difference in changes in TG levels was noted at 3 days after surgery between MCT/LCT intravenous LE group and the omega-3-enriched intravenous LE group (p=0.008). Conclusion: The intravenous omega-3-enriched LE had a better TG-lowering effect than the MCT/LCT intravenous LE in children undergoing gastrointestinal surgery.

참고문헌 (20)

  1. Wang J, "Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols", long-chain triacylglycerols in gastrointestinal surgery patients : a randomized clinical trial, 2012, pp.28, 623~629
  2. Ammoury RF, "Malabsorptive disorders of childhood", Pediatr Rev, 31, pp.407~415 (2010)
  3. Skillman HE, "Nutrition therapy in critically ill infants and children", JPEN J Parenter Enteral Nutr, 32, pp.520~534 (2008)
  4. Chawla BK, "Profound systemic inflammatory response syndrome following nonemergent intestinal surgery in children", J Pediatr Surg, 48, pp.1936~1940 (2013)
  5. Buchman A, "Total parenteral nutrition-associated liver disease", JPEN J Parenter Enteral Nutr, 26(5Suppl), pp.S43~48 (2002)
  6. Mullick FG, "Total parenteral nutrition : a histopathologic analysis of the liver changes in 20 children", Mod Pathol, 7, pp.190~194 (1994)
  7. Grau T, "Liver dysfunction associated with artificial nutrition in critically ill patients", Crit Care, 11, pp.R10~ (2007)
  8. Pereira-da-Silva L, "Parenteral nutrition-associated cholestasis and triglyceridemia in surgical term and near-term neonates : A pilot randomized controlled trial of two mixed intravenous lipid emulsions", Clin Nutr ESPEN, 22, pp.7~12 (2017)
  9. Kasirer Y, "SMOFlipid protects preterm neonates against perinatal nutrition-associated cholestasis", Am J Perinatol, 36, pp.1382~1386 (2019)
  10. Koletzko B, "Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR)", J Pediatr Gastroenterol Nutr (2005)
  11. Wu MH, "Randomized clinical trial of new intravenous lipid(SMOFlipid 20%)versus medium-chain triglycerides", long-chain triglycerides in adult patients undergoing gastrointestinal surgery, 2014, pp.38, 800~808
  12. Ma CJ, "Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients", Nutr J, 14, pp.9~ (2015)
  13. Jiang W, "The effects of two mixed intravenous lipid emulsions on clinical outcomes in infants after gastrointestinal surgery : a prospective, randomized study", Pediatr Surg Int, 35, pp.347~355 (2019)
  14. Diamond IR, "The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease", Pediatr Surg Int, 24, pp.773~778 (2008)
  15. Costa S, "Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis", Ital J Pediatr, 44, pp.101~ (2018)
  16. Carpentier YA, "Recent developments in lipid emulsions : relevance to intensive care", Nutrition, 13(9 Suppl), pp.73S~78S (1997)
  17. Wiik H, "Inflammatory response following abdominal surgery and its modulation by recombinant human granulocyte colonystimulating factor (rhg-csf, filgrastim)" (2002), Oulu University Press
  18. Hallay J, "Hepatobiliary response in postoperative lipid therapy in gastrointestinal surgery", Hepatogastroenterology, 57, pp.1069~1073 (2010)
  19. Berger MM, "Fish oil after abdominal aorta aneurysm surgery", Eur J Clin Nutr, 62, pp.1116~1122 (2008)
  20. Shearer GC, "Fish oil--how does it reduce plasma triglycerides", Biochim Biophys Acta, 1821, pp.843~851 (2012)

관련 논문AI추천

미숙아의 정맥영양제 투여에 의한 간기능 부작용 발생에 있어서 Fish Oil 함유 대 Soybean Oil 함유 지방유제의 영향비교권지은, 김순주, 김은영, 나현오, 박애령, 왕선희, 황보신이한국병원약사회 · 병원약사회지2017 · 제34권 제1호정맥영양요법을 시행 중인 고중성지방혈증 환자에서 fish oil이 함유된 지방유제 투여 효과 분석권지은, 김순주, 나현오, 박애령, 오소영한국병원약사회 · 병원약사회지2013 · 제30권 제5호Intestinal Hypoganglionosis Leading to Intestinal Failure and the Compassionate Use of OmegavenTMFauzia Shakeel, Michael Wilsey, Paul Danielson, Racha Khalaf, Sara Karjoo대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2017 · 제20권 제1호Clinical Factors Affecting Lipid Metabolism and Optimal Dose of Heparin in Preterm Infants on Parenteral Nutrition김병일, 양혜란, 임미선, 최창원대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2013 · 제16권 제2호Omega-3 Polyunsaturated Fatty Acid for Cholestasis due to BileDuct Paucity박희선, 배선환, 윤익진, 한혜승대한소아소화기영양학회 · Pediatric Gastroenterology, Hepatology & Nutrition2014 · 제17권 제2호소아중환자의 정맥영양 시작시기에 따른 임상적 효과 평가김경원, 김재송, 손은선, 윤정인, 정민재, 한소연한국병원약사회 · 병원약사회지2019 · 제36권 제3호

이 간행물의 다른 논문 (12건)